T/FIF Portfolio Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (143)	10/22/1998 10:55:00 AM
From: David Cathcart	Read Replies (1) of 1073

Rick, Richard Bagnell pointed out that MGI Pharma is conducting their own phase II trials for MGI 114 for prostrate, ovarian and pancreatic cancer. The National Cancer Institute in presently conducting phase II MGI 114 trials for non-small cell lung cancer, metastatic kidney cancer and colon cancer, plus a phase I pediatric study for recurrent or refractory solid tumors. To see the current NCI MGI 114 trials progress, go to the NCI PDQ® Clinical Trials Search Form at: cancernet.nci.nih.gov Type “MGI” in the drug field of the search form and it will bring up the current MGI 114 trials they are sponsoring. My understanding is that the NCI plans to add eight additional phase II MGI 114 trials in the coming weeks (months?). David

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next